EARLIEST-AI Study type: Two-phase, multi-reader, blinded retrospective observational study based on data from a single clinic. The primary objective of the study is to assess the sensitivity and specificity of radiologists and Artificial Intelligence (AI) in interpreting mammographic examinations for breast cancer detection in a scenario where no previous examinations are available, and to compare the diagnostic performance of radiologists with and without AI support. The secondary objectives of the study are to assess the independent diagnostic performance of Computer Aided Detection (CAD) software, including sensitivity and specificity in identifying histopathologically confirmed breast cancer cases; to assess inter-reader and intra-reader variability in interpretation with and without AI support; to assess the agreement between AI outputs and histopathological findings; and to assess the impact of mammogram technical parameters on AI performance. Time frame: Review of a subset of mammograms randomly selected from those performed between January 1, 2012 and December 31, 2024. Imaging findings were classified according to the Breast Imaging Reporting and Data System (BI-RADS). Inclusion criteria: 1. Female patients aged 30 years or older. 2. One or more mammograms performed between January 1, 2012 and December 31, 2024. 3. Meets one of the following criteria: 3.1 Histopathologically confirmed diagnosis of breast cancer within 6 months of mammogram, 3.2 or two consecutive mammograms with BI-RADS 1 or BI-RADS 2. Exclusion criteria: 1. Mammograms of poor quality or artifacts that do not allow for reliable assessment. 2. History of breast surgery or previous breast cancer treatment that has significantly altered breast morphology. 3. Data deficiencies, including: 3.1. lack of previous histopathological data 3.2. or lack of available follow-up data.
Age range
30 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Standalone reader sensitivity
Timeframe: through study completion, an average of 1 year
Standalone CAD sensitivity
Timeframe: through study completion, an average of 1 year
Augmented Reader sensitivity
Timeframe: through study completion, an average of 1 year
Standalone reader detection to diagnostic time (MAE)
Timeframe: through study completion, an average of 1 year
Augmented reader detection to diagnostic time (MAE)
Timeframe: through study completion, an average of 1 year